FA vs. RTO, CART, ALLE, MEDP, ULS, WPP, GLOB, HQY, STN, and BILI
Should you be buying First Advantage stock or one of its competitors? The main competitors of First Advantage include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), Stantec (STN), and Bilibili (BILI). These companies are all part of the "business services" industry.
First Advantage vs.
First Advantage (NYSE:FA) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.
In the previous week, Rentokil Initial had 27 more articles in the media than First Advantage. MarketBeat recorded 27 mentions for Rentokil Initial and 0 mentions for First Advantage. First Advantage's average media sentiment score of 1.84 beat Rentokil Initial's score of 0.07 indicating that First Advantage is being referred to more favorably in the media.
First Advantage presently has a consensus target price of $53.29, suggesting a potential upside of 186.48%. Rentokil Initial has a consensus target price of $29.00, suggesting a potential upside of 21.77%. Given First Advantage's stronger consensus rating and higher possible upside, analysts plainly believe First Advantage is more favorable than Rentokil Initial.
Rentokil Initial has higher revenue and earnings than First Advantage. Rentokil Initial is trading at a lower price-to-earnings ratio than First Advantage, indicating that it is currently the more affordable of the two stocks.
First Advantage has a net margin of 0.65% compared to Rentokil Initial's net margin of 0.00%. First Advantage's return on equity of 13.16% beat Rentokil Initial's return on equity.
First Advantage has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.
First Advantage received 25 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 56.86% of users gave First Advantage an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.
94.9% of First Advantage shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 5.3% of First Advantage shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
First Advantage beats Rentokil Initial on 14 of the 19 factors compared between the two stocks.
Get First Advantage News Delivered to You Automatically
Sign up to receive the latest news and ratings for FA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
First Advantage Competitors List
Related Companies and Tools
This page (NYSE:FA) was last updated on 1/21/2025 by MarketBeat.com Staff